Corient Private Wealth’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$462K Buy
19,799
+5,176
+35% +$93.7K ﹤0.01% 2075
2025
Q4
$209K Sell
14,623
-4,590
-24% -$86.8K ﹤0.01% 2578
2025
Q3
$476K Buy
19,213
+157
+0.8% +$3.5K ﹤0.01% 1819
2025
Q2
$432K Buy
19,056
+6,813
+56% +$161K ﹤0.01% 1781
2025
Q1
$371K Buy
12,243
+817
+7% +$31.1K ﹤0.01% 1744
2024
Q4
$453K Buy
11,426
+1,892
+20% +$85.3K ﹤0.01% 1678
2024
Q3
$605K Buy
9,534
+5,980
+168% +$432K ﹤0.01% 1633
2024
Q2
$240K Sell
3,554
-2
-0.1% -$140 ﹤0.01% 2025
2024
Q1
$282K Sell
3,556
-275
-7% -$22.5K ﹤0.01% 1927
2023
Q4
$298K Buy
+3,831
New +$284K ﹤0.01% 1865

Other funds holding ACHC

Corient Private Wealth's ACHC Position: Q1 2026 in Review

Corient Private Wealth increased its Acadia Healthcare (ACHC) stake by 35% in Q1 2026, buying an estimated $93.7K and bringing the position to 19,799 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

Corient Private Wealth first reported a position in ACHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $605K in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Corient Private Wealth held 19,799 shares of Acadia Healthcare worth $462K as of Q1 2026.
  • Corient Private Wealth bought 5,176 Acadia Healthcare shares in Q1 2026, an estimated $93.7K.
  • Acadia Healthcare made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2075 holding.
  • Corient Private Wealth first reported a position in Acadia Healthcare in Q4 2023 and has held it in 10 quarters since.
  • Corient Private Wealth's Acadia Healthcare position peaked at $605K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.